Back
Cemex SAB de CV Vs. Crinetics Pharmaceuticals Industry Stock Comparison
Buy
66
CX
Cemex SAB de CV
Last Price:
$5.59
Seasonality Move:
4.67%
Sell
8
CRNX
Crinetics Pharmaceuticals
Last Price:
$40.59
Seasonality Move:
-9.08%
Buy
66
Cemex SAB de CV (CX)
is a Buy
Is Cemex SAB de CV a Buy, Sell or Hold?
-
The current Cemex SAB de CV [CX] share price is $5.69. The Score for CX is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
CX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
8
Crinetics Pharmaceuticals (CRNX)
is a Sell
Is Crinetics Pharmaceuticals a Buy, Sell or Hold?
-
The current Crinetics Pharmaceuticals [CRNX] share price is $48.50. The Score for CRNX is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
-
CRNX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
CX Stock Price Chart
What is Cemex SAB de CV's stock price today?
-
The Cemex SAB de CV share price today is $5.69Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CX is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRNX Stock Price Chart
What is Crinetics Pharmaceuticals's stock price today?
-
The Crinetics Pharmaceuticals share price today is $48.50Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRNX is experiencing slight selling pressure.
CX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.02 | Buy |
Relative Strength Index (14 RSI): | 52.28 | Buy |
Chaikin Money Flow: | 9827521 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.59 - 5.75) | Buy |
Bollinger Bands (100): | (5.48 - 6.2) | Sell |
CRNX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.69 | Sell |
Relative Strength Index (14 RSI): | 34.32 | Sell |
Chaikin Money Flow: | -235099 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (51.1 - 56.94) | Sell |
Bollinger Bands (100): | (51.5 - 57.46) | Sell |
CX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.67 | Buy |
20-day SMA: | 5.64 | Buy |
50-day SMA: | 5.57 | Buy |
200-day SMA: | 6.57 | Sell |
8-day EMA: | 5.68 | Buy |
20-day EMA: | 5.66 | Buy |
50-day EMA: | 5.69 | Buy |
200-day EMA: | 6.27 | Sell |
CRNX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 50.85 | Sell |
20-day SMA: | 53.18 | Sell |
50-day SMA: | 55.63 | Sell |
200-day SMA: | 51.03 | Sell |
8-day EMA: | 50.82 | Sell |
20-day EMA: | 52.67 | Sell |
50-day EMA: | 54.22 | Sell |
200-day EMA: | 49.96 | Sell |
Cemex SAB de CV Earnings Growth & CX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and an increase next year of $0.13 per share.
Crinetics Pharmaceuticals Earnings Growth & CRNX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.47 per share.
Cemex SAB de CV Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Crinetics Pharmaceuticals Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |